Private Advisor Group, LLC Exact Sciences Corp Transaction History

Private Advisor Group, LLC

  • $15.6 Billion
  • Q3 2024

A detailed history of Private Advisor Group, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Private Advisor Group, LLC holds 25,049 shares of EXAS stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,049
Previous 25,621 2.23%
Holding current value
$1.44 Million
Previous $1.08 Million 57.58%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
SELL
$42.43 - $70.83 $24,269 - $40,514
-572 Reduced 2.23%
25,049 $1.71 Million
Q2 2024

Aug 05, 2024
SELL
$41.33 - $74.26 $55,919 - $100,473
-1,353 Reduced 5.02%
25,621 $1.08 Million
Q1 2024

Apr 30, 2024
BUY
$56.27 - $73.77 $168,753 - $221,236
2,999 Added 12.51%
26,974 $1.86 Million
Q4 2023

Feb 06, 2024
BUY
$59.06 - $75.72 $81,443 - $104,417
1,379 Added 6.1%
23,975 $1.77 Million
Q3 2023

Nov 02, 2023
SELL
$65.94 - $99.04 $429,796 - $645,542
-6,518 Reduced 22.39%
22,596 $1.54 Million
Q2 2023

Aug 09, 2023
SELL
$62.68 - $95.05 $18,929 - $28,705
-302 Reduced 1.03%
29,114 $2.73 Million
Q1 2023

May 10, 2023
SELL
$47.19 - $70.77 $11,372 - $17,055
-241 Reduced 0.81%
29,416 $1.99 Million
Q4 2022

Jan 18, 2023
BUY
$30.35 - $53.15 $50,896 - $89,132
1,677 Added 5.99%
29,657 $0
Q3 2022

Oct 14, 2022
SELL
$31.97 - $49.37 $2,078 - $3,209
-65 Reduced 0.23%
27,980 $909,000
Q2 2022

Jul 13, 2022
SELL
$35.61 - $76.23 $263,015 - $563,034
-7,386 Reduced 20.85%
28,045 $1.11 Million
Q1 2022

May 12, 2022
BUY
$57.56 - $82.54 $234,499 - $336,267
4,074 Added 12.99%
35,431 $2.48 Million
Q4 2021

Feb 10, 2022
SELL
$72.5 - $100.68 $520,115 - $722,278
-7,174 Reduced 18.62%
31,357 $2.44 Million
Q3 2021

Oct 14, 2021
BUY
$90.24 - $124.05 $958,168 - $1.32 Million
10,618 Added 38.04%
38,531 $3.68 Million
Q2 2021

Aug 12, 2021
BUY
$93.66 - $139.27 $374,920 - $557,497
4,003 Added 16.74%
27,913 $3.47 Million
Q1 2021

Apr 22, 2021
BUY
$116.57 - $155.01 $44,646 - $59,368
383 Added 1.63%
23,910 $3.15 Million
Q4 2020

Apr 01, 2021
BUY
$99.61 - $142.12 $499,842 - $713,158
5,018 Added 27.11%
23,527 $3.12 Million
Q3 2020

Nov 02, 2020
SELL
$72.92 - $102.01 $193,310 - $270,428
-2,651 Reduced 12.53%
18,509 $1.89 Million
Q2 2020

Aug 17, 2020
BUY
$55.75 - $92.75 $240,171 - $399,567
4,308 Added 25.56%
21,160 $1.84 Million
Q1 2020

May 12, 2020
SELL
$37.9 - $104.44 $12,469 - $34,360
-329 Reduced 1.91%
16,852 $977,000
Q4 2019

Feb 10, 2020
BUY
$77.66 - $99.74 $566,762 - $727,902
7,298 Added 73.84%
17,181 $1.59 Million
Q3 2019

Nov 13, 2019
BUY
$90.37 - $122.49 $82,055 - $111,220
908 Added 10.12%
9,883 $893,000
Q2 2019

Aug 14, 2019
BUY
$89.51 - $118.04 $71,070 - $93,723
794 Added 9.71%
8,975 $1.06 Million
Q1 2019

May 13, 2019
SELL
$61.98 - $96.5 $137,099 - $213,458
-2,212 Reduced 21.28%
8,181 $708,000
Q4 2018

Feb 11, 2019
BUY
$56.04 - $82.66 $86,077 - $126,965
1,536 Added 17.34%
10,393 $655,000
Q3 2018

Nov 01, 2018
BUY
$48.29 - $80.6 $427,704 - $713,874
8,857 New
8,857 $699,000
Q2 2018

Aug 09, 2018
SELL
$37.84 - $69.96 $213,341 - $394,434
-5,638 Closed
0 $0
Q1 2018

May 09, 2018
BUY
$39.82 - $57.53 $224,505 - $324,354
5,638 New
5,638 $227,000
Q4 2017

Feb 07, 2018
SELL
$46.49 - $60.51 $606,229 - $789,050
-13,040 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$37.05 - $47.12 $192,659 - $245,024
5,200 Added 66.33%
13,040 $626,000
Q2 2017

Aug 10, 2017
BUY
N/A
7,840
7,840 $292,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email